Janet Conway, Ph.D. has acquired a remarkable level of expertise in the area of Ophthalmic Innovation and has provided valuable leadership, guidance and insight to some of the most relevant companies in the space. She has served as Global Head of Ophthalmic Business Development at Pfizer and Pharmacia as well as interim Head of Business Development at Bausch & Lomb. 

She was a member of the Board of Directors at Aerie Pharmaceuticals and was also Head of Product Development at IOLAB Ophthalmic Pharmaceuticals (J&J), Olympus Medical Instrument Division (US), VimRx Pharmaceuticals, M6 Pharmaceuticals, and a member of the business development team at J&J World Wide Vision Care Franchise. She has advised extensively with  The Magnum Group.

Dr. Conway received her Ph.D. in visual neurophysiology from the Massachusetts Institute of Technology and completed a post-doctoral fellowship in visual neuroscience at the University of California Irvine.  Following her post-doctoral training she joined Allergan as a Drug Discovery Scientist.  She has provided consulting services to numerous pharmaceutical companies in the US and Europe for over 15 years.